These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3157051)

  • 21. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of histochemical and biochemical assays for estrogen receptor in human breast cancer cell lines.
    Parl FF; Wetherall NT; Halter S; Schuffman S; Mitchell WM
    Cancer Res; 1984 Jan; 44(1):415-21. PubMed ID: 6690057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
    Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
    J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G; Beadle G; Thomas S; Mengersen K; Stein S
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of malignant breast tumors containing estrogen receptors].
    El'tsina NV
    Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
    [No Abstract]   [Full Text] [Related]  

  • 26. [Histochemical study of estradiol receptors and morphologic parameters in breast cancer].
    Berger G; Frappart L; Feroldi J
    Bull Assoc Anat (Nancy); 1982 Dec; 66(195):431-9. PubMed ID: 6305447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemical characteristics of mammary carcinomas with estrogen-negative and progesterone-positive receptors].
    Sundblad AS; Caprarulo L
    Medicina (B Aires); 1996; 56(6):683-9. PubMed ID: 9284572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
    Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
    J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1.
    Pintens S; Neven P; Drijkoningen M; Van Belle V; Moerman P; Christiaens MR; Smeets A; Wildiers H; Vanden Bempt I
    J Clin Pathol; 2009 Jul; 62(7):624-8. PubMed ID: 19561231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor immunocytochemical assay (ERICA) and laminin detection in 130 breast carcinomas and computerized (Samba 200) multiparametric quantitative analysis on tissue sections.
    Charpin C; Martin PM; Lissitzky JC; Jacquemier J; Kopp F; Pourreau-Schneider N; Lavaut MN; Toga M
    Bull Cancer; 1986; 73(6):651-64. PubMed ID: 3567371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of estrogen binding in human mammary carcinoma by immunofluorescence: a new technic utilizing the binding hormone in a polymerized state.
    Pertschuk LP
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):771-4. PubMed ID: 183254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochemical and competitive protein binding assays for estrogen receptor in breast disease. A comparative study of 62 cases.
    Jacobs SR; Wolfson WL; Cheng L; Lewin KJ
    Cancer; 1983 May; 51(9):1621-4. PubMed ID: 6831365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Present status of estrogen-receptor immunohistochemistry.
    van Bogaert LJ
    Acta Histochem; 1985; 76(1):29-35. PubMed ID: 2409727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates.
    Masood S
    Am J Clin Pathol; 1991 Jan; 95(1):35-40. PubMed ID: 1987750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of ER-negative breast cancer: where do we stand?
    Cazzaniga M; Bonanni B
    Eur J Cancer Prev; 2012 Mar; 21(2):171-81. PubMed ID: 21968686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Various amounts of estrogen receptors in breast neoplasms].
    Jakesz R; Kolb R; Reiner G; Chaput B; Schemper M
    Helv Chir Acta; 1979 Feb; 45(6):763-7. PubMed ID: 429178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A histochemical study on human breast carcinoma, fibroadenosis and fibroadenomas].
    Zhao FZ
    Zhonghua Bing Li Xue Za Zhi; 1985 Mar; 14(1):67-70. PubMed ID: 2935284
    [No Abstract]   [Full Text] [Related]  

  • 39. Cellular estrogen and progesterone receptors in mammary carcinoma.
    Lee SH
    Am J Clin Pathol; 1980 Mar; 73(3):323-9. PubMed ID: 7361711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochemical study of estrogen receptor in human mammary cancer.
    Lee SH
    Am J Clin Pathol; 1978 Aug; 70(2):197-203. PubMed ID: 80958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.